Page last updated: 2024-10-31

metyrapone and Intestinal Diseases

metyrapone has been researched along with Intestinal Diseases in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
REED, PI1
CLAYMAN, CB1
PALMER, WL1

Other Studies

1 other study available for metyrapone and Intestinal Diseases

ArticleYear
ADRENOCORTICAL AND PITUITARY RESPONSIVENESS FOLLOWING LONG-TERM, HIGH DOSAGE ACTH AND STEROID TREATMENT OF PATIENTS WITH CHRONIC INTESTINAL DISORDERS.
    Acta gastro-enterologica Belgica, 1964, Volume: 27

    Topics: Adrenocorticotropic Hormone; Colitis; Colitis, Ulcerative; Crohn Disease; Enteritis; Humans; Intesti

1964